unknown
Stage
2018
Founded
2
Investors
About
XyloCor Therapeutics develops proprietary gene therapies to treat advanced coronary artery disease and other cardiovascular conditions.
Explore XyloCor's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.